ACLARION, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
ACLARION, INC. (ACON) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$2.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-06
- ACLARION, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$2.75M.
- ACLARION, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$2.85M.
- ACLARION, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$1.89M.
- ACLARION, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$1.71M.
- ACLARION, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$7.24M.
- ACLARION, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$7.05M.
- ACLARION, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$4.91M.
- ACLARION, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$7.48M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.75M 10-Q · filed 2026-08-06 | -$5.60M 10-Q · filed 2026-08-06 | -$7.49M derived: sum of 3 quarters · filed 2026-08-06 | -$9.20M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$2.85M 10-Q · filed 2026-05-13 | -$4.74M derived: sum of 2 quarters · filed 2026-05-13 | -$6.45M derived: sum of 3 quarters · filed 2026-05-13 | -$8.05M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | -$1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$3.60M derived: sum of 2 quarters · filed 2026-03-18 | -$5.20M derived: sum of 3 quarters · filed 2026-08-06 | -$7.24M 10-K · filed 2026-03-18 | |||
| 2025-09-30 | -$1.71M 10-Q · filed 2025-11-12 | -$3.31M derived: sum of 2 quarters · filed 2026-08-06 | -$5.35M 10-Q · filed 2025-11-12 | -$7.39M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$1.60M 10-Q · filed 2026-08-06 | -$3.64M 10-Q · filed 2026-08-06 | -$5.68M derived: sum of 3 quarters · filed 2026-08-06 | -$7.06M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$2.04M 10-Q · filed 2026-05-13 | -$4.08M derived: sum of 2 quarters · filed 2026-05-13 | -$5.46M derived: sum of 3 quarters · filed 2026-05-13 | -$6.70M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$3.42M derived: sum of 2 quarters · filed 2026-03-18 | -$4.65M derived: sum of 3 quarters · filed 2026-03-18 | -$7.05M 10-K · filed 2026-03-18 | -$6.99M 10-K · filed 2025-04-09 | ||
| 2024-09-30 | -$1.38M 10-Q · filed 2025-11-12 | -$2.62M derived: sum of 2 quarters · filed 2025-11-12 | -$5.02M 10-Q · filed 2025-11-12 | -$6.28M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$1.24M 10-Q · filed 2025-08-14 | -$3.64M 10-Q · filed 2025-08-14 | -$4.90M derived: sum of 3 quarters · filed 2025-08-14 | -$5.90M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$2.40M 10-Q · filed 2025-05-15 | -$3.66M derived: sum of 2 quarters · filed 2025-05-15 | -$4.66M derived: sum of 3 quarters · filed 2025-05-15 | -$6.13M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | -$2.26M derived: sum of 2 quarters · filed 2025-04-09 | -$3.73M derived: sum of 3 quarters · filed 2025-04-09 | -$4.91M 10-K · filed 2025-04-09 | |||
| 2023-09-30 | -$998.01K 10-Q · filed 2024-11-14 | -$2.46M derived: sum of 2 quarters · filed 2024-11-14 | -$3.65M 10-Q · filed 2024-11-14 | -$4.59M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$1.46M 10-Q · filed 2024-08-14 | -$2.65M 10-Q · filed 2024-08-14 | -$3.59M derived: sum of 3 quarters · filed 2024-08-14 | -$5.23M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$1.18M 10-Q · filed 2024-05-15 | -$2.13M derived: sum of 2 quarters · filed 2024-05-15 | -$3.76M derived: sum of 3 quarters · filed 2024-05-15 | -$7.44M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$944.61K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$2.58M derived: sum of 2 quarters · filed 2024-03-28 | -$6.26M derived: sum of 3 quarters · filed 2024-03-28 | -$7.48M 10-K · filed 2024-03-28 | -$7.61M 10-K · filed 2023-02-27 | ||
| 2022-09-30 | -$1.63M 10-Q · filed 2023-11-14 | -$5.32M derived: sum of 2 quarters · filed 2023-11-14 | -$6.54M 10-Q · filed 2023-11-14 | -$6.28M 10-Q · filed 2022-11-14 | -$7.27M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$3.68M 10-Q · filed 2023-08-25 | -$4.91M 10-Q · filed 2023-08-25 | -$4.64M 10-Q · filed 2022-08-15 | -$5.63M derived: sum of 3 quarters · filed 2023-08-25 | -$8.59M derived: sum of 4 quarters · filed 2023-08-25 | ||
| 2022-03-31 | -$936.09K 10-Q · filed 2023-07-03 | -$1.95M derived: sum of 2 quarters · filed 2023-07-03 | -$4.90M derived: sum of 3 quarters · filed 2023-07-03 | ||||
| 2021-12-31 | -$1.01M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | -$3.97M derived: sum of 2 quarters · filed 2023-06-12 | -$4.95M 10-K/A · filed 2023-06-12 | ||||
| 2021-09-30 | -$2.95M 10-Q · filed 2022-11-14 | -$3.94M 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$983.70K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |